Clinical Trial Update: Pharmacoinvasive Therapy With Prourokinase [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating pharmacoinvasive therapy with prourokinase in patients with ST-segment Elevation Myocardial Infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• ProUrokinase (pro-urokinase)

Snippet

Sponsor: Suzhou Landing Pharmaceuticals | Conditions: ST-segment Elevation Myocardial Infarction (STEMI) | Phase 2, Phase 3 | Status: COMPLETED